Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay
- Author
- WALLEMACQ, Pierre1 ; GOFFINET, Jean-Sebastien1 ; SCHMID, Rainer W7 ; O'MORCHOE, Susan2 ; ROSIERE, Thomas2 ; MAINE, Gregory T2 ; LABALETTE, Myriam3 ; AIMO, Giuseppe4 ; DICKSON, Diana5 ; SCHMIDT, Ed5 ; SCHWINZER, Reinhard6
[1] Cliniques universitaires St. Luc, Universite catholique de Louvain, Brussels, Belgium
[2] Abbott Diagnostics, Abbott Park, Illinois, United States
[3] Lille Hospital, Loos, France
[4] Molinette Hospital, Torino, Italy
[5] Fujirebio Diagnostics, Malvem, Pennsylvania, United States
[6] Medizinische Hochschule Hannover, Hannover, Germany
[7] Medizinische Universität Wien, Vienna, Austria - Source
Therapeutic drug monitoring. 2009, Vol 31, Num 2, pp 198-204, 7 p ; ref : 20 ref
- CODEN
- TDMODV
- ISSN
- 0163-4356
- Scientific domain
- Pharmacology drugs
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- FK 506 LC-MSMS immunoassay method evaluation tacrolimus therapeutic drug monitoring
- Keyword (fr)
- Evaluation Immunodépresseur Immunomodulateur Méthode immunologique Suivi thérapeutique pharmacologique Tacrolimus Inhibiteur de la calcineurine Inhibiteur synthèse protéique Lactone Macrolide
- Keyword (en)
- Evaluation Immunosuppressive agent Immunomodulator Immunological method Therapeutic drug monitoring Tacrolimus Calcineurin inhibitor Protein synthesis inhibitor Lactone Macrolide
- Keyword (es)
- Evaluación Inmunodepresor Inmunomodulador Método inmunológico Monitorización farmacoterapéutica Tacrolimús Inhibidor calcineurina Inhibidor síntesis proteica Lactona Macrólido
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments
- Discipline
- General pharmacology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21326505
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/FTD.0b013e31819c6a37 
https://dx.doi.org/10.1097/FTD.0b013e31819c6a37
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/FTD.0b013e31819c6a37\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Therapeutic drug monitoring\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ther. drug monit\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"198\";s:8:\"\u0000*\u0000epage\";s:3:\"204\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0163-4356\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"WALLEMACQ\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Pierre\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:24:\"GOFFINET, Jean-Sebastien\";i:1;s:16:\"SCHMID, Rainer W\";i:2;s:16:\"O'MORCHOE, Susan\";i:3;s:15:\"ROSIERE, Thomas\";i:4;s:16:\"MAINE, Gregory T\";i:5;s:17:\"LABALETTE, Myriam\";i:6;s:14:\"AIMO, Giuseppe\";i:7;s:14:\"DICKSON, Diana\";i:8;s:11:\"SCHMIDT, Ed\";i:9;s:19:\"SCHWINZER, Reinhard\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"TDMODV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/FTD.0b013e31819c6a37\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Therapeutic drug monitoring\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ther. drug monit\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"198\";s:8:\"\u0000*\u0000epage\";s:3:\"204\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0163-4356\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"WALLEMACQ\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Pierre\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:24:\"GOFFINET, Jean-Sebastien\";i:1;s:16:\"SCHMID, Rainer W\";i:2;s:16:\"O'MORCHOE, Susan\";i:3;s:15:\"ROSIERE, Thomas\";i:4;s:16:\"MAINE, Gregory T\";i:5;s:17:\"LABALETTE, Myriam\";i:6;s:14:\"AIMO, Giuseppe\";i:7;s:14:\"DICKSON, Diana\";i:8;s:11:\"SCHMIDT, Ed\";i:9;s:19:\"SCHWINZER, Reinhard\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"TDMODV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/FTD.0b013e31819c6a37\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/FTD.0b013e31819c6a37\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Therapeutic drug monitoring\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ther. drug monit\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"198\";s:8:\"\u0000*\u0000epage\";s:3:\"204\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0163-4356\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"WALLEMACQ\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Pierre\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:24:\"GOFFINET, Jean-Sebastien\";i:1;s:16:\"SCHMID, Rainer W\";i:2;s:16:\"O'MORCHOE, Susan\";i:3;s:15:\"ROSIERE, Thomas\";i:4;s:16:\"MAINE, Gregory T\";i:5;s:17:\"LABALETTE, Myriam\";i:6;s:14:\"AIMO, Giuseppe\";i:7;s:14:\"DICKSON, Diana\";i:8;s:11:\"SCHMIDT, Ed\";i:9;s:19:\"SCHWINZER, Reinhard\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"TDMODV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/FTD.0b013e31819c6a37\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Therapeutic drug monitoring\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ther. drug monit\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"198\";s:8:\"\u0000*\u0000epage\";s:3:\"204\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0163-4356\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"WALLEMACQ\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Pierre\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:24:\"GOFFINET, Jean-Sebastien\";i:1;s:16:\"SCHMID, Rainer W\";i:2;s:16:\"O'MORCHOE, Susan\";i:3;s:15:\"ROSIERE, Thomas\";i:4;s:16:\"MAINE, Gregory T\";i:5;s:17:\"LABALETTE, Myriam\";i:6;s:14:\"AIMO, Giuseppe\";i:7;s:14:\"DICKSON, Diana\";i:8;s:11:\"SCHMIDT, Ed\";i:9;s:19:\"SCHWINZER, Reinhard\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"TDMODV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/FTD.0b013e31819c6a37\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Therapeutic drug monitoring\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ther. drug monit\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"198\";s:8:\"\u0000*\u0000epage\";s:3:\"204\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0163-4356\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"WALLEMACQ\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Pierre\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:24:\"GOFFINET, Jean-Sebastien\";i:1;s:16:\"SCHMID, Rainer W\";i:2;s:16:\"O'MORCHOE, Susan\";i:3;s:15:\"ROSIERE, Thomas\";i:4;s:16:\"MAINE, Gregory T\";i:5;s:17:\"LABALETTE, Myriam\";i:6;s:14:\"AIMO, Giuseppe\";i:7;s:14:\"DICKSON, Diana\";i:8;s:11:\"SCHMIDT, Ed\";i:9;s:19:\"SCHWINZER, Reinhard\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"TDMODV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
